Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 04:56 ET | Source: Research and Markets

Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global cancer immunotherapy...
February 18, 2025 09:06 ET | Source: Research and Markets

Oncolytic Virus Cancer Therapy Pipeline Market Report: Competitive Analysis of Oncostar, Astellas, and Johnson & Johnson, T-VEC, Pelareorep, and VSV Lead Innovations

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Cancer Therapy Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.The oncolytic virus cancer therapy...
November 22, 2024 08:25 ET | Source: Research and Markets

Cancer Gene Therapy Strategic Business Report 2024: Global Market to Grow by $6.5 Billion by 2030 - Rising Interest in Oncolytic Virus Therapy Generates New Opportunities

Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Gene...
August 22, 2024 04:04 ET | Source: Research and Markets

Oncolytic Virus Therapy Research Report 2024-2030: Market Poised for Expansion Across Multiple Cancer Types, Including Melanoma and Ovarian Cancer

Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
June 27, 2024 06:03 ET | Source: Research and Markets

Global Oncolytic Virus Therapy Industry Research 2024-2032: Strategic Collaborations to Increase Market Share, Oncolytic Wild-type Viruses Driving Therapeutic Innovation, North America Leads

Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
June 25, 2024 12:27 ET | Source: Research and Markets

Oncology Drugs Market Projected to Surge to $340 Billion by 2031 - Insights Into the Products, Technologies, Grades, Applications, End-users, and Regions

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
May 14, 2024 08:50 ET | Source: Research and Markets

Global Oncolytic Virus Immunotherapy Market & Clinical Trials Insight - A USD 1.50 Billion+ Market Opportunity by 2030

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering....
March 04, 2024 11:02 ET | Source: Research and Markets

Global, Oncolytic Virus Therapy Research Report 2024: Market to Reach $53.06 Billion by 2028, Driven by Strategic Partnerships and Rising Awareness

Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
October 23, 2023 09:00 ET | Source: Emergen Research

Global Oncolytic Virus Therapies Market Size to Reach USD 1,546.51 Million in 2032 | Emergen Research

Vancouver, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global oncolytic virus therapies market size is expected to reach USD 1,546.51 Million at a steady CAGR of 26.2% in 2032, according to latest...